|
Human and Animal Cells
|
HYT-1(RCB1297)
,
THP-1
|
77871
|
T cell receptor-engineered T cells derived from target human leukocyte antigen-DPB1-specific T cell can be a potential tool for therapy against leukemia relapse following allogeneic hematopoietic cell transplantation.
|
Nagoya J Med Sci |
2023-11-1 |
Pubmed
Full text
|
